TABLE 3

Pneumonia outcomes stratified by baseline blood eosinophil group

Low-eosinophil group
(<150 cells·µL−1)
High-eosinophil group
(≥150 cells·µL−1)
Interaction HR and p-value
Pneumonia episodes1.10 (0.99–1.24)
p=0.09
n=2832
1.05 (0.97–1.13)
p=0.24
n=6321
0.95 (0.83–1.08)
p=0.44
Hospitalisation due to pneumonia1.26 (1.05–1.50)
p=0.01
n=2910
1.00 (0.88–1.14)
p>0.99
n=6499
0.80 (0.64–0.99)
p=0.04
Death due to pneumonia1.19 (0.50–2.84)
p=0.70
n=2918
0.53 (0.27–1.05)
p=0.07
n=6517
0.44 (0.65–4.42)
p=0.14

Data are presented as hazard ratio (HR) (95% CI), unless otherwise stated. HRs are for time to first event after treatment initiation, for inhaled corticosteroid (ICS) versus non-ICS treatment. HRs are from Cox regression including interaction term and adjusted for covariates as detailed in figure 1.